Arkolith/Insider Trading/CARM/Form 4

Klichinsky Michael

Chief Scientific OfficerCarisma Therapeutics Inc. (CARM) · full profile →Form 4 · filed Oct 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Sell(S)57K$0.25$14K0
Oct 7, 2025Option exercise(M)57K$0.11$6K57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Option exercise(M)57K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-097928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML